These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 25452001

  • 1. Synthesis and SAR of thieno[3,2-b]pyridinyl urea derivatives as urotensin-II receptor antagonists.
    Lim CJ, Oh SA, Lee BH, Oh KS, Yi KY.
    Bioorg Med Chem Lett; 2014 Dec 15; 24(24):5832-5835. PubMed ID: 25452001
    [Abstract] [Full Text] [Related]

  • 2. Benzo[b]thiophene-2-carboxamide derivatives as potent urotensin-II receptor antagonists.
    Lim CJ, Woo SE, Ko SI, Lee BH, Oh KS, Yi KY.
    Bioorg Med Chem Lett; 2016 Oct 01; 26(19):4684-4686. PubMed ID: 27597245
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and SAR of 5-aryl-furan-2-carboxamide derivatives as potent urotensin-II receptor antagonists.
    Lim CJ, Kim NH, Park HJ, Lee BH, Oh KS, Yi KY.
    Bioorg Med Chem Lett; 2019 Feb 15; 29(4):577-580. PubMed ID: 30611618
    [Abstract] [Full Text] [Related]

  • 4. 2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6,7,8,9-tetrahydropyrido[2',3':4,5]thieno[2,3-b]pyridine derivatives as selective progesterone receptor agonists.
    Wang Y, Duraiswami C, Madauss KP, Tran TB, Williams SP, Deng SJ, Graybill TL, Hammond M, Jones DG, Grygielko ET, Bray JD, Thompson SK.
    Bioorg Med Chem Lett; 2009 Sep 01; 19(17):4916-9. PubMed ID: 19664922
    [Abstract] [Full Text] [Related]

  • 5. A novel series of histamine H4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: comparison of hERG binding and target residence time with PF-3893787.
    Andaloussi M, Lim HD, van der Meer T, Sijm M, Poulie CB, de Esch IJ, Leurs R, Smits RA.
    Bioorg Med Chem Lett; 2013 May 01; 23(9):2663-70. PubMed ID: 23558237
    [Abstract] [Full Text] [Related]

  • 6. Optimization of piperidin-4-yl-urea-containing melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Reducing hERG-associated liabilities.
    Berglund S, Egner BJ, Gradén H, Gradén J, Morgan DG, Inghardt T, Giordanetto F.
    Bioorg Med Chem Lett; 2009 Aug 01; 19(15):4274-9. PubMed ID: 19500982
    [Abstract] [Full Text] [Related]

  • 7. Ureas with histamine H3-antagonist receptor activity--a new scaffold discovered by lead-hopping from cinnamic acid amides.
    Lau JF, Jeppesen CB, Rimvall K, Hohlweg R.
    Bioorg Med Chem Lett; 2006 Oct 15; 16(20):5303-8. PubMed ID: 16908150
    [Abstract] [Full Text] [Related]

  • 8. Predicted ligands for the human urotensin-II G protein-coupled receptor with some experimental validation.
    Kim SK, Goddard WA, Yi KY, Lee BH, Lim CJ, Trzaskowski B.
    ChemMedChem; 2014 Aug 15; 9(8):1732-43. PubMed ID: 24989481
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System.
    Clozel M, Binkert C, Birker-Robaczewska M, Boukhadra C, Ding SS, Fischli W, Hess P, Mathys B, Morrison K, Müller C, Müller C, Nayler O, Qiu C, Rey M, Scherz MW, Velker J, Weller T, Xi JF, Ziltener P.
    J Pharmacol Exp Ther; 2004 Oct 15; 311(1):204-12. PubMed ID: 15146030
    [Abstract] [Full Text] [Related]

  • 11. Reduction of hERG inhibitory activity in the 4-piperidinyl urea series of H3 antagonists.
    Berlin M, Lee YJ, Boyce CW, Wang Y, Aslanian R, McCormick KD, Sorota S, Williams SM, West RE, Korfmacher W.
    Bioorg Med Chem Lett; 2010 Apr 01; 20(7):2359-64. PubMed ID: 20188550
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 2,4-Diaminothienopyrimidines as orally active antimalarial agents.
    González Cabrera D, Le Manach C, Douelle F, Younis Y, Feng TS, Paquet T, Nchinda AT, Street LJ, Taylor D, de Kock C, Wiesner L, Duffy S, White KL, Zabiulla KM, Sambandan Y, Bashyam S, Waterson D, Witty MJ, Charman SA, Avery VM, Wittlin S, Chibale K.
    J Med Chem; 2014 Feb 13; 57(3):1014-22. PubMed ID: 24446664
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synthesis and structure-activity relationships of thieno[2,3-d]pyrimidine-2,4-dione derivatives as potent GnRH receptor antagonists.
    Guo Z, Chen Y, Wu D, Zhu YF, Struthers RS, Saunders J, Xie Q, Chen C.
    Bioorg Med Chem Lett; 2003 Oct 20; 13(20):3617-22. PubMed ID: 14505682
    [Abstract] [Full Text] [Related]

  • 17. 1,4-Dihydroindeno[1,2-c]pyrazoles with acetylenic side chains as novel and potent multitargeted receptor tyrosine kinase inhibitors with low affinity for the hERG ion channel.
    Dinges J, Albert DH, Arnold LD, Ashworth KL, Akritopoulou-Zanze I, Bousquet PF, Bouska JJ, Cunha GA, Davidsen SK, Diaz GJ, Djuric SW, Gasiecki AF, Gintant GA, Gracias VJ, Harris CM, Houseman KA, Hutchins CW, Johnson EF, Li H, Marcotte PA, Martin RL, Michaelides MR, Nyein M, Sowin TJ, Su Z, Tapang PH, Xia Z, Zhang HQ.
    J Med Chem; 2007 May 03; 50(9):2011-29. PubMed ID: 17425296
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model.
    Lescot E, Sopkova-de Oliveira Santos J, Colloc'h N, Rodrigo J, Milazzo-Segalas I, Bureau R, Rault S.
    Proteins; 2008 Oct 03; 73(1):173-84. PubMed ID: 18409194
    [Abstract] [Full Text] [Related]

  • 20. Discovery and optimization of 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives as a novel class of selective cannabinoid CB2 receptor agonists.
    van der Stelt M, Cals J, Broeders-Josten S, Cottney J, van der Doelen AA, Hermkens M, de Kimpe V, King A, Klomp J, Oosterom J, Pols-de Rooij I, de Roos J, van Tilborg M, Boyce S, Baker J.
    J Med Chem; 2011 Oct 27; 54(20):7350-62. PubMed ID: 21923175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.